MedPath

the effect of treatment of helicobacter pylori (HP) infection on improvement of metabolic syndrome (MS)

Not Applicable
Conditions
Condition 1: metabolic syndrome. Condition 2: Helicobacter pylori infection.
Metabolic disorder, unspecified
Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Registration Number
IRCT2015020420951N1
Lead Sponsor
research department of medical college of QUMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

inclusion: concomitant metabolic syndrome and helicobacter pylori
exclusion: no consent; any other internal or cardiac disease; intolerance to the prescribed drugs

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Waist circimference. Timepoint: at the start and end of the study. Method of measurement: cm.;Fasting blood sugar. Timepoint: at the start and end of the study. Method of measurement: mg/dl.;Serum triglyceride. Timepoint: at the start and end of the study. Method of measurement: mg/dl.;Blood pressure. Timepoint: at the start and end of the study. Method of measurement: milimeter of mercury.;Body mass index. Timepoint: at the start and end of the study. Method of measurement: kg/m2.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath